UPDATE: Goldman Sachs Downgrades Intuitive Surgical to Neutral on Dissapointing 2Q2013 Results

In a report published on Tuesday, Goldman Sachs analyst David H. Roman downgraded Intuitive Surgical

to Neutral and lowered the price target to $500 from $676. In the report, Goldman Sachs noted, "While procedure volumes were somewhat better than most had feared (no material change in growth vs. Q1), the US capital equipment business looks to be facing material incremental headwinds". Intuitive Surgical closed on Monday at $500.08.